Electrocardiography Screening for Hypertrophic Cardiomyopathy.

Area of Science:

• Cardiology
• Medical Diagnostics
• Computational Biology

Background:

• Hypertrophic cardiomyopathy (HCM) is a primary cause of sudden cardiac death in athletes.
• Current electrocardiogram (ECG) screening methods face criticism due to cost-effectiveness issues and high false-positive rates.

Purpose of the Study:

• To evaluate a highly automated software algorithm for high-throughput, population-based screening of HCM.
• To address limitations associated with traditional population-based screening programs.

Main Methods:

• A proprietary computed algorithm was developed using voltage and Seattle ECG criteria.
• Various cut points for Q-wave depth, Q-wave duration, ST depression, T-wave inversion, and left ventricular voltage were analyzed.
• Receiver operating characteristic curves were used to optimize algorithm sensitivity and specificity.

Main Results:

• The automated algorithm achieved 88.6% sensitivity and 98% specificity for HCM detection via ECG.
• Physician interpretation using Seattle Criteria yielded 90.2% sensitivity and 96% specificity.
• Optimized automated software demonstrated 98% sensitivity and 96% specificity, with improved sensitivity when voltage criteria were included.

Conclusions:

• Computer-automated ECG screening for HCM is a feasible approach.
• Larger-scale evaluations of automated ECG algorithms in diverse populations are necessary.